These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27933404)

  • 1. Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism.
    Chapuis J; Flaig A; Grenier-Boley B; Eysert F; Pottiez V; Deloison G; Vandeputte A; Ayral AM; Mendes T; Desai S; Goate AM; Kauwe JSK; Leroux F; Herledan A; Demiautte F; Bauer C; Checler F; Petersen RC; Blennow K; Zetterberg H; Minthon L; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Albert M; Moghekar A; O'Brien R; Peskind ER; Malmanche N; Schellenberg GD; Dourlen P; Song OR; Cruchaga C; Amouyel P; Deprez B; Brodin P; Lambert JC;
    Acta Neuropathol; 2017 Jun; 133(6):955-966. PubMed ID: 27933404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner.
    Eysert F; Coulon A; Boscher E; Vreulx AC; Flaig A; Mendes T; Hughes S; Grenier-Boley B; Hanoulle X; Demiautte F; Bauer C; Marttinen M; Takalo M; Amouyel P; Desai S; Pike I; Hiltunen M; Chécler F; Farinelli M; Delay C; Malmanche N; Hébert SS; Dumont J; Kilinc D; Lambert JC; Chapuis J
    Mol Psychiatry; 2021 Oct; 26(10):5592-5607. PubMed ID: 33144711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidate-based screening via gene modulation in human neurons and astrocytes implicates FERMT2 in Aβ and TAU proteostasis.
    Sullivan SE; Liao M; Smith RV; White C; Lagomarsino VN; Xu J; Taga M; Bennett DA; De Jager PL; Young-Pearse TL
    Hum Mol Genet; 2019 Mar; 28(5):718-735. PubMed ID: 30371777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.
    Lorenzo A; Yuan M; Zhang Z; Paganetti PA; Sturchler-Pierrat C; Staufenbiel M; Mautino J; Vigo FS; Sommer B; Yankner BA
    Nat Neurosci; 2000 May; 3(5):460-4. PubMed ID: 10769385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
    Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway-based analysis of genome-wide siRNA screens reveals the regulatory landscape of APP processing.
    Camargo LM; Zhang XD; Loerch P; Caceres RM; Marine SD; Uva P; Ferrer M; de Rinaldis E; Stone DJ; Majercak J; Ray WJ; Yi-An C; Shearman MS; Mizuguchi K
    PLoS One; 2015; 10(2):e0115369. PubMed ID: 25723573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntingtin associated protein 1 regulates trafficking of the amyloid precursor protein and modulates amyloid beta levels in neurons.
    Yang GZ; Yang M; Lim Y; Lu JJ; Wang TH; Qi JG; Zhong JH; Zhou XF
    J Neurochem; 2012 Sep; 122(5):1010-22. PubMed ID: 22731248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNX27 and SORLA Interact to Reduce Amyloidogenic Subcellular Distribution and Processing of Amyloid Precursor Protein.
    Huang TY; Zhao Y; Li X; Wang X; Tseng IC; Thompson R; Tu S; Willnow TE; Zhang YW; Xu H
    J Neurosci; 2016 Jul; 36(30):7996-8011. PubMed ID: 27466343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in phosphatidylethanolamine levels affect the generation of Aβ.
    Nesic I; Guix FX; Vennekens K; Michaki V; Van Veldhoven PP; Feiguin F; De Strooper B; Dotti CG; Wahle T
    Aging Cell; 2012 Feb; 11(1):63-72. PubMed ID: 22023223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRE1 signaling exacerbates Alzheimer's disease pathogenesis.
    Duran-Aniotz C; Cornejo VH; Espinoza S; Ardiles ÁO; Medinas DB; Salazar C; Foley A; Gajardo I; Thielen P; Iwawaki T; Scheper W; Soto C; Palacios AG; Hoozemans JJM; Hetz C
    Acta Neuropathol; 2017 Sep; 134(3):489-506. PubMed ID: 28341998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
    Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
    Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ji Y; Quartermain D; Jensen CH; Duff K; Nixon RA; Gruen RJ; Wisniewski T
    J Neuropathol Exp Neurol; 2004 May; 63(5):418-28. PubMed ID: 15198121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
    Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
    J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
    Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
    FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
    Gandy S; Petanceska S
    Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.